In thyroid cancer, lncRNA HAGLR increases IGF2BP2 expression, and IGF2BP2 recognizes the m6A modification of c-MYC and leads to increased c-MYC expression, which promotes cancer progression 156. This evidence concerns the gene MYC and cancer.